Contract 75N98024A00156
Diagnocine Llc · Department Of Health And Human Services · August 26, 2024
Diagnocine Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 26, 2024 for an undisclosed amount of work in biological product (except diagnostic) manufacturing. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 29, 2025. If all options are exercised, the contract could reach $10.00 million.
Contract details
- PIID
- 75N98024A00156
- Award type
- —
- Pricing
- Firm Fixed Price
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 26, 2024
- Latest action
- August 29, 2025
Description
O/M ITEMS ONLY: LIFE SCIENCE REAGENTS, ANTIBODIES, CHEMICAL/NATURAL COMPOUNDS, PCR ENZYMES, LABORATORY SUPPLIES
Modification timeline
-
August 29, 2025Mod P00002$0
-
May 29, 2025Mod P00001$0
-
August 26, 2024Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N98024A00156?
Contract 75N98024A00156 is a federal contract awarded to Diagnocine Llc by Department Of Health And Human Services on August 26, 2024 for an undisclosed amount of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N98024A00156?
Diagnocine Llc won contract 75N98024A00156 from Department Of Health And Human Services.
How much is contract 75N98024A00156 worth?
Contract 75N98024A00156 has obligated $0 to date but carries a potential ceiling of $10.00 million if fully funded and all options are exercised.